Anisomycin-induced GATA-6 degradation accompanying a decrease of proliferation of colorectal cancer cell

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Biology

Background:

• Transcription factor GATA-6 is crucial for normal cell differentiation but is overexpressed in gastrointestinal cancers.
• Overexpressed GATA-6 promotes cancer cell proliferation and survival.
• JNK signaling cascade activation leads to GATA-6 proteolysis.

Purpose of the Study:

• To investigate the effect of anisomycin, a JNK activator, on GATA-6 in colorectal cancer cells.
• To evaluate anisomycin's efficacy in inhibiting colorectal cancer cell proliferation, both alone and in combination with 5-FU.

Main Methods:

• Utilized the DLD-1 colorectal cancer cell line.
• Administered anisomycin to induce JNK activation and observed its effects on GATA-6 localization.
• Assessed cell proliferation using plate and 3D spheroid cultures.
• Evaluated combination therapy with 5-fluorouracil (5-FU).

Main Results:

• Anisomycin induced nuclear export of GATA-6 in DLD-1 cells.
• Anisomycin inhibited DLD-1 cell proliferation via G2/M arrest without inducing apoptosis.
• Anisomycin suppressed DLD-1 cell growth in spheroid cultures.
• Combination of anisomycin and 5-FU demonstrated significant synergistic growth inhibition in spheroid cultures.

Conclusions:

• Disrupting GATA-6 function via JNK activation may be a viable strategy for colorectal cancer chemotherapy.
• Anisomycin shows potential as an adjuvant therapy, enhancing the efficacy of 5-FU in colorectal cancer treatment.